TEK and neoplasm: AMG386, a peptibody that inhibits Ang1/Ang2‐TIE2 binding and impairs tumor angiogenesis (Coxon et al,2010; Scholz et al,2016) significantly reduced the growth of established B16F10 tumors compared to control (Fig 6A and B).